[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 3,975.00 3,900.00 4,050.00 3,975.00 3,975.00 3,975.00 990 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10.3 8.2 139.4 28.5 207

Bioventix Share Discussion Threads

Showing 1151 to 1173 of 1350 messages
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
DateSubjectAuthorDiscuss
20/1/2020
14:33
Think you'll find it's been better as LTBH. Any trader would have taken a quick profit years ago, and still be waiting for an entry point to get back in...!
stepone68
20/1/2020
14:12
Sounds like a good strategy......this has been a good a good trading share.
11_percent
20/1/2020
13:30
Sold my remaining holding here this morning. This bounce has been great- however we need positive results on troponin and vitamin d revenue to plough on. If things dip back down to 3500 territory then I’ll look to get back in again.
diviincomesearch
17/1/2020
09:42
Or - is something else going on here?
trident5
17/1/2020
09:26
That was some share tip.....
11_percent
16/1/2020
15:59
This pretty much doubles every two years. Long may it continue :-)
stepone68
16/1/2020
14:24
On the verge of a major breakout to New Highs.
chester
16/1/2020
13:46
Nice to be back over £40. Hope it holds.
igbertsponk
15/1/2020
09:26
Yes it will crash. As all the shareholders are disloyal short-term punters.... Amusing.
igbertsponk
15/1/2020
08:46
When did they report a year of 1% sales growth?
stepone68
15/1/2020
06:23
If they report another year of 1% sales growth this will crash
mastermasterbaker
13/1/2020
16:39
On a shareprice of £39.00 the yield is 3.08% if the special div is included which gives a div of £1.20 last year! To be more annuity like should the yield reduce to perhaps 1.5%. Even FGT shows a yield of below 2%. To yield 2% the share would have to be on £60.00.
a1samu
13/1/2020
14:02
That's just a Tweet linking to the same article that has already been discussed, and quoted in its entirety just above...! And to access it I was forced to follow that twitter account which I assume belongs to you? Well, I've unfollowed and blocked it after that experience.
stepone68
10/1/2020
16:18
One of my best AIM buys. Bought over 4 years ago. My initial reasons for buying were that BVXP was a very small company (only 13 employees), no debts, a unique product which has a huge potential, a dividend rising at 30% p.a. (Subsequently dropped to only 20% increases p.a!), throwing off a lot of surplus cash. Didn't appear in many financial articles. Very large moat. Now has a potential tie up with Siemens and still below its peak price of £41. Only one broker following the share (I think this may change shortly). Up over 10% today alone!
scillyfool
10/1/2020
08:48
Oh dear- isn’t that the kiss of death when Questor tips things with their track record! I don’t have premium so if someone could post the full article that would be good.
diviincomesearch
10/1/2020
08:43
hTTps://www.telegraph.co.uk/investing/shares/questor-aim-stock-tip-year-antibody-firm-strong-antidote-competition/?WT.mc_id=tmg_share_tw
carcosa
10/1/2020
08:15
Tipped by Questor
mngf
08/1/2020
18:29
Yes, slowly grinding upwards. I don’t see the share price having much upwards momentum unless there’s some serious news on troponin at the next results. The share price is still fairly rich based on the latest results.
diviincomesearch
08/1/2020
17:01
HNY holders - gradually creeping back up where she belongs.
igbertsponk
19/12/2019
18:42
There is a detailed report on Bioventix's recent AGM which can be found in our members area here: hTTps://sharesoc.ning.com/xn/detail/6389471:Comment:55228 To access the report, you'll need to be a full member of ShareSoc, which is a not-for-profit organisation that supports individual shareholders and campaigns for shareholder rights. If you're not already a member you can join here: hTTps://www.sharesoc.org/membership/ Once you've joined, you'll receive an invitation to register for our "members network" private social network, from where you'll be able to access the report (and reports on 100s of other meetings). If you're already a member and have any difficulty accessing the report, please do not hesitate to contact us here: hTTps://www.sharesoc.org/contact-us/
sharesoc
19/12/2019
16:05
Hopefully significant hTTPs://emj.bmj.com/content/37/1/8?utm_source=alert&utm_medium=email&utm_campaign=emj&utm_content=toc&utm_term=18122019 Objectives To directly compare the diagnostic accuracy of four decision aids (Troponin-only Manchester Acute Coronary Syndromes (T-MACS), History, ECG, Age, Risk factors and Troponin (HEART), Thrombolysis in Myocardial Infarction (TIMI) and Emergency Department Assessment of Chest Pain (EDACS)) used to expedite the early diagnosis of acute coronary syndromes (ACS) in the ED. Conclusions In this study, T-MACS could rule out AMI in 46.5% patients with 99.2% sensitivity. EDACS could rule out AMI in 48.3% patients with lower sensitivity, although the difference was not statistically significant. The HEART and TIMI scores had lower diagnostic accuracy.
chippyfriday
19/12/2019
09:11
Https://swiss-nordic-bio-2020.b2match.io/participants/92 The CEO of CardiNor is presenting at Swiss-Nordic Bio in February. CardiNor is developing a secretoneurin assay using a Bioventix antibody. Secretoneurin is an experimental cardiac biomarker for which clinical utility has not yet been established. This year's version of his profile indicates that "The first product is now ready for launch in the research market" and that they are seeking to raise Eur 2m to pursue CE marking. Encouraging that RuO (research use only) launch of secretoneurin is imminent and that things are, more generally, progressing. RuO sales unlikely to be meaningful as secretoneurin not currently widely researched.
gsbmba99
18/12/2019
07:29
hTTps://maynardpaton.com/2019/12/17/bioventix-satisfactory-2019-results-reveal-yet-another-special-dividend-and-indicate-growth-during-2020-2025-depends-entirely-on-troponin/ Without advfn's corruption of http
alter ego
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
ADVFN Advertorial
Your Recent History
LSE
BVXP
Bioventix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210923 12:13:42